Effect of dolutegravir on ferritin, iron, and C-reactive protein among people living with HIV and co-infections

To assess virological outcomes, iron, ferritin and C-reactive protein (CRP) levels among people living with HIV (PLWH) and co-infections after initiating or re-initiating dolutegravir-based ART.

Educational Objectives

Educational Aim:

After completing this article, the reader will be able to describe the impact of HIV co-infections on inflammation, iron metabolism, and viral suppression in patients treated with dolutegravir-based antiretroviral therapy.

Educational Outcomes:
Upon completion of this module practitioners should have a clear understanding of:

1. The effect of common HIV co-infections on viral load, C-reactive protein, ferritin, and iron levels in people living with HIV.
2. The impact of dolutegravir-based antiretroviral therapy on inflammation and iron mark ers over six months of treatment.
3. The clinical significance of persistent inflammation in patients with HIV co-infections despite successful virological suppression.

Instructions for this Module

• Read the supplied reading material and complete the quiz that follows;
• You have three attempts to pass the quiz;
• The pass grade is 70%;
• You need to pass the quiz to claim your CPD certificate;
• Please click on the CPD certificate link below to claim your CPD certificate and to update your CPD Manager.

If you need any assistance to complete this module, please Contact us